Scholars Central

Research articlePublished 29 Jul 2020

Metformin Sensitizes Ovarian Cancer Cells to Chemotherapy By Inhibiting ERCC1 Expression

Authors: Cuili Zhang, Xiaofeng Li, Haonan Li, Yongqi Liang, Jing Zhang, Likun Liu, Weiling Li

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Metformin is an oral anti-hyperglycemic agent of the biguanide family, which is used first-line for type II diabetes with few side-effects. Clinical studies demonstrated that diabetics taking metformin significantly decreased incidence of cancer, which has opened the prologue of metformin in cancer research. Since recent studies have revealed the inhibition of cancer cells’ growth and remission time prolonged effect of the anti-diabetic reagent metformin but the underlying mechanisms of ovarian cancer remain unclear, we investigated the potential effects and possible molecular mechanisms of metformin on chemosensitivity of ovarian cancer cells. Cell proliferation were determined with combination of cisplatin and metformin by MTT and ERCC1 expression level were analyzed by Western blotting assay. In addition, ERCC1 plasmid transfection was used to explore ERCC1 roles in the synergistic effect of cisplatin and metformin on ovarian cancer cells. The results indicated that treatment with metformin enhanced the sensitivity of ovarian cells to cisplatin and cisplatin induced ERCC1 expression could be suppressed by metformin. Furthermore, over-expression of ERCC1 in ovarian cancer cells could abrogate the synergistic effect of cisplatin and metformin. In conclusion, metformin enhanced the sensitivity of ovarian cancer cells to cisplatin by down-regulation the expression of ERCC1 and may be a prospective chemotherapeutic agent or a chemosensitizer in future ovarian cancer treatment.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Oncology Research and Treatment.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Oncology Research and Treatment
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Cuili Zhang”
  • BylineArticles whose byline prints “Xiaofeng Li”
  • BylineArticles whose byline prints “Haonan Li”
  • BylineArticles whose byline prints “Yongqi Liang”
  • BylineArticles whose byline prints “Jing Zhang”
  • BylineArticles whose byline prints “Likun Liu”
  • BylineArticles whose byline prints “Weiling Li”